Table 2 Univariate analysis of clinicopathological factors and response to treatment
Factor | ICR (%) | CR (%) | Odds ratio | 95% CI | P |
|---|---|---|---|---|---|
Age (years) | |||||
 ⩽65 | 4 (41.7) | 5 (58.3) | |||
 >65 | 3 (30.0) | 7 (70.0) | 1.867 | 0.283–12.312 | 0.5166 |
T stage | |||||
 T1+T2 | 2(25) | 6 (75) | |||
 T3+T4 | 5 (45.5) | 6 (54.5) | 0.40 | 0.055–2.934 | 0.3674 |
Haemoglobin level | |||||
 Low (⩽11.5 g dl−1) | 4 (40.0) | 6 (60.0) | |||
 High (>11.5 g dl−1) | 3 (33.3) | 6 (66.7) | 1.333 | 0.311–12.842 | 0.465 |
Differentiation | |||||
 Well | 3 (42.9) | 4 (57.1) | |||
 Moderate+poor | 4 (36.4) | 8 (63.6) | 1.500 | 0.220–10.220 | 0.6787 |
Pattern of invasion | |||||
 1+2+3 | 3 (33.3) | 6 (66.7) | |||
 4 | 4 (40.0) | 6 (60.0) | 0.750 | 0.115–4.899 | 0.750 |
Expression of EGFR | |||||
 Negative | 2 (16.7) | 10(83.3) | |||
 Positive | 5 (71.4) | 2 (28.6) | 0.08 | 0.009–0.748 | 0.0267 |
Expression of VEGF | |||||
 Negative | 3 (37.5) | 5 (62.5) | |||
 Positive | 4 (36.4) | 7 (63.6) | 0.952 | 0.144–6.282 | 0.9596 |
BVD | |||||
 Low(⩽11) | 5 (71.4) | 2 (28.6) | |||
 High(>11) | 2 (16.7) | 10 (83.3) | 12.50 | 1.338–116.82 | 0.0267 |
